Search Results - "Reichelderfer, M"

Refine Results
  1. 1

    FDG-PET in inflammatory bowel disease by Spier, B J, Perlman, S B, Reichelderfer, M

    “…Accurate, inexpensive, non-invasive studies in evaluation of inflammatory bowel disease (IBD) would represent a significant advancement in identifying and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease by Murray, Joseph A, Kelly, Ciarán P, Green, Peter H.R, Marcantonio, Annette, Wu, Tsung-Teh, Mäki, Markku, Adelman, Daniel C

    Published in Gastroenterology (New York, N.Y. 1943) (01-03-2017)
    “…Background & Aims Gluten ingestion leads to symptoms and small intestinal mucosal injury in patients with celiac disease. The only option is the strict…”
    Get full text
    Journal Article
  4. 4

    Low-attenuation oral GI contrast agents in abdominal-pelvic computed tomography by Hebert, J J, Taylor, A J, Winter, T C, Reichelderfer, M, Weichert, J P

    Published in Abdominal imaging (01-01-2006)
    “…We designed and evaluated a low-attenuation oral contrast agent for abdominal-pelvic computed tomography (CT). In vitro studies, were performed initially to…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole by Nelson, W W, Vermeulen, L C, Geurkink, E A, Ehlert, D A, Reichelderfer, M

    Published in Archives of internal medicine (1960) (11-09-2000)
    “…Omeprazole and lansoprazole are 2 proton pump inhibitors (PPIs) currently available in the United States. Both PPIs are approved for the treatment of…”
    Get more information
    Journal Article
  8. 8

    Predictors of early recurrence of benign esophageal strictures by Said, Adnan, Brust, Donald J, Gaumnitz, Eric A, Reichelderfer, Mark

    Published in The American journal of gastroenterology (01-06-2003)
    “…In the era of liberal proton pump inhibitor (PPI) use, benign esophageal strictures remain a significant management problem, with 30–40% of patients…”
    Get full text
    Journal Article
  9. 9

    Intestinal Adenomas Can Develop with a Stable Karyotype and Stable Microsatellites by Haigis, Kevin M., Caya, James G., Reichelderfer, Mark, Dove, William F.

    “…Loss of function of the adenomatous polyposis coli (APC)/Apc tumor suppressor gene occurs early in the etiology of intestinal cancer in mammals. In human…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Treatment of symptomatic gastroesophageal reflux using the Angelchik prosthesis by Starling, J R, Reichelderfer, M O, Pellett, J R, Belzer, F O

    Published in Annals of surgery (01-06-1982)
    “…During the past 20 months, 28 patients with symptomatic gastroesophageal reflux were treated with the Angelchik anti-reflux prosthesis. The patients ranged in…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Cholecystitis caused by hemocholecyst from underlying malignancy by Heise, Charles P, Giswold, Mary, Eckhoff, Devin, Reichelderfer, Mark

    Published in The American journal of gastroenterology (01-03-2000)
    “…Massive hemobilia is a well recognized clinical entity, particularly when it presents with jaundice, GI bleeding, and biliary pain. However, occult hemobilia…”
    Get full text
    Journal Article
  18. 18

    Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history by Pickhardt, Perry J, Dr, Kim, David H, MD, Pooler, B Dustin, MD, Hinshaw, J Louis, MD, Barlow, Duncan, MD, Jensen, Don, MD, Reichelderfer, Mark, MD, Cash, Brooks D, MD

    Published in The lancet oncology (01-07-2013)
    “…Summary Background The clinical relevance and in-vivo growth rates of small (6–9 mm) colorectal polyps are not well established. We aimed to assess the…”
    Get full text
    Journal Article
  19. 19
  20. 20